(NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy ...

While Alnylam’s recent reduced revenue guidance spooked investors, analysts remain broadly bullish on the biotech’s ...

Today, the Honourable Marjorie Michel, Minister of Health, announced the appointment of Dr. George Mutwiri to the Canadian ...

While industry leaders are unsure whether the U.S. or China will prevail, they are largely united in the belief that Europe ...

The first-time CEO says her own sponsors took chances on her—and that industry leaders need to do the same to rebuild ...

Oversubscribed financing led by Juvia Group, welcomes an expanded syndicate of leading institutional investors, reflecting ...

Evaluating subcutaneous SKYRIZI against stringent endoscopic outcomes demonstrates its potential to help CD patients achieve ...

Published in Antimicrobial Agents and Chemotherapy, the peer-reviewed study is the first to directly compare AvantGuard’s new ...

Preliminary findings from Part 1 of the Phase 2/3 ANDECAL study highlight a potential therapeutic approach for fibrodysplasia ...

Former Genentech Senior Vice President Brings More Than 25 Years of Biopharma Experience to Guide Continued Growth and ...

Battelle has been awarded a Defense Technical Information Center (DTIC) Information Analysis Center Multiple Award Contract ...

Phoenix Children’s today announced that Kevin Snyder, MAOM, has been named Vice President of Marketing & Communications. In ...